CCL5/regulated on activation, normal T expressed and secreted production (RANTES) is a principal CC chemokine, and can activate macrophages and Th1 lymphocytes, however, little is known about the CCL5 profiles associated with active tuberculosis (TB). In this study, we investigated the production of CCL5 by the peripheral blood mononuclear cells (PBMCs) of patients with active pulmonary TB after stimulation with Triton X-100 soluble proteins (TSP) or the 30-kDa antigen. The profiles of cytokines/chemokines [CXCL8/interleukin (IL)-8, IL-12 p40, and interferon (IFN)-γ] were also examined by PBMCs from TB patients, and compared with those obtained from healthy tuberculin reactors (HTR). Concordant with earlier studies, IFN-γ production was significantly depressed in the PBMCs from TB patients compared with those from HTR. In addition, the CCL5, but not CXCL8, levels in the PBMCs from TB patients were significantly depressed after stimulation for 18 hr compared to those in the PBMCs from HTRs. The CCL5 release was not significantly correlated with the release of IFN-γ in the cells from TB patients and HTRs. Further, inhibitor studies show that the 30-kDa-or TSP-induced CCL5 mRNA expression is sensitive to inhibitors of mitogen-activated protein kinase kinase (MEK) 1/2 and Janus kinase (JAK) 2, but not p38, pathway activation, suggesting a MEK1/2-or JAK2-based mechanism is responsible for modulating of the CCL5 expression in human PBMCs. Collectively, these data suggest that TB patients show depressed production of CCL5 secretion, which can be modulated by MEK-and JAK2-based transcriptional regulatory mechanisms, in response to the mycobacterial antigens.
INTRODUCTION
Tuberculosis (TB) is a chronic disease requiring the constant expression of cellular immunity to limit bacterial growth. A complex interaction between host and mycobacteria plays an important role for the regulation of the development of cellular immunity, which affects both protective and inflammatory roles (12) (27, 31) . In addition, our recent study has described the in vitro induction of CC chemokine CCL20 and modulation of its receptor CCR6 expression by mycobacterial 30-kDa antigen (Ag) (26) , indicating that Mtb infection is able to orchestrate recruitment of immune cells to the site of infection. Understanding the relative roles of the cytokines in mediating protection and immunopathology will be important in light of the development towards novel therapeutic modalities against this notorious pathogen.
Several cytokines and chemokines have been identified
as critical factors in the protective immunity and pathophysiology of TB (18) . Chemokines are critical in this response since they are both chemotactic and immunoregulatory molecules (42). Chemokines are small-molecularmass chemotactic cytokines (8~14 kDa) that mediate constitutive and inflammatory recruitment of leukocytes from the blood into tissues. Chemokines are grouped into four structurally related families (designated CC, CXC, C, or CX 3 C), determined by the numbers of amino acids that separate the two cysteine residues closest to the amino terminus (31) . Among the many chemokines, CCL5/ regulated-upon-activation, normal T-cell-expressed and -secreted chemokine (RANTES), a CC chemokine, is produced by a variety of cell types, including T cells and macrophages. CCL5 has a selective action as a monocyte/ macrophage attractant in the airways and strongly induces migration of T cells with the memory phenotype (3).
Expression of CCL5 has been detected predominantly in the macrophages and endothelial cells in the granulomatous lesions of both sarcoidosis and TB patients, suggesting that CCL5 production in delayed-type hypersensitivity granulomas may play a role in the selective accumulation of macrophages and memory T helper lymphocytes characterizing this type of cell-mediated immune reaction (9) .
In addition, CCL5 protein production was synergistically induced by both IFN-γ and TNF-α in human umbilical venous endothelial cells, whereas the Th2-type cytokines IL-4 and IL-13 significantly inhibit the CCL5 secretion (28) . Further, IFN-γ deficient type 1 granulomas showed decreased levels of TNF-α and CCL5, suggesting that CCL5 production is associated with protective cytokines (6) . Recent studies using various leukocyte populations 
MATERIALS AND METHODS

Subjects
Whole blood sample was obtained from a total of 20 TB patients and 20 HTRs. All subjects gave their informed consent before being enrolled in the study. The HTR subjects were recruited from medical college students at Konyang University Hospital, and they had no previous history of 
Isolation of human PBMCs and Ag stimulation
PBMCs were isolated from whole blood by density sedimentation over Histopaque-1077 (Sigma, St. Louis, MO, USA). The PBMCs were suspended at a density of 1 ×10
6 viable cells/ml in complete medium [RPMI 1640 (Gibco-BRL, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (Gibco-BRL), sodium pyruvate, nonessential amino acids, 100 IU/ml penicillin G, and 100 μg/ml streptomycin]. PBMCs were then stimulated with 1.0 μg/ml 30-kDa or TSP Ag, and incubated at 37℃ in a humidified, 5% CO 2 atmosphere until used for supernatant collection. LPS (1 μg/ml; Sigma) and phytohaemoagglutinin (PHA) (1 μg/ml; Sigma) were used as positive controls for the Ag stimulation in this study.
Materials and reagents
The specific inhibitors of MEK, PD98059 and U0126, and p38 MAPK, SB203580 were purchased from Calbio- 
Statistical analysis
For statistical analysis, the data obtained from independent experiments were presented as the mean ± SD; they were analyzed using a Student t-test or simple linear regression analysis. P level < 0.05 was regarded as statistically significant.
RESULTS
Purification of the 30-kDa Ag and isolation of the TSP Ag from Mtb H37Rv
The TSP protein, not a single protein, but a complex 
IFN-γ and IL-12p40 production by PBMC stimulated with 30-kDa and TSP Ags in TB patients and HTRs
The induction of potent Th1 immune response is mainly involved in the generation of protective immunity against TB (12, 29) . We compared the Th1 cytokine, IFN-γ and Th1 driving cytokine, IL-12p40 induction to 30-kDa and TSP Ags in the PBMC from TB patients and HTRs. The B A Figure 3 . CCL5 (A) and CXCL8 (B) production in PBMC from TB patients and HTRs in response to the 30-kDa and TSP Ags. The production of CCL5 and CXCL8 by PBMC from TB patients and HTRs was determined after in vitro 18 hr stimulation with the 30-kDa and TSP Ags (1 μg/ml). Data are plotted as individual points on the graph (TB patient, n=20; HTR, n=20). The protein levels of CCL5 and CXCL8 in culture supernatants were measured by specific ELISA. *, p<0.05; **, p<0.01. Un, unstimulated. 
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PBMC from TB patients was significantly increased than corresponding values in HTRs at 18 h. Medium control level of CXCL8 was also significantly increased in PBMC from TB patients, when compared to those from HTR (Fig.   3B ). Moreover, CXCL8 levels in monocyte, as a major source of the CXCL8 were also up-regulated in TB patients, when cultured with 30-kDa or TSP Ag (data not shown).
There was no significant difference between 30-kDa and TSP Ags to CCL5 or CXCL8 production (p>0.1 for both Ags).
We also determined whether the individual CCL5 or Fig. 5 ). In contrast, SB203580, a selective inhibitor of p38 MAPK, had no significant effect on the CCL5 expression (Fig. 5) .
DISCUSSION
Chemokines have been identified as key factors in orchestrating the development of protective TB granuloma (6, 7) . Previous studies showed that the elevated levels of CXCL8, CCL5, and CCL2 are observed in association with TB pleuritis, supporting the roles of chemokines that play a central role in a development of immunity against TB (7, 11) . In this study, we have focused on the chemokine profiles, specifically on the CCL5 and CXCL8 production, Agonist stimulation of TLRs leads to the activation of MAPK cascades, including ERK1/2 (17) . These signaling pathways are implicated in activation of the inflammatory and antimicrobial innate immune response to mycobacteria (17) . We previously showed that the 30-kDa Ag-induced CCL20 mRNA expression involves ERK1/2, p38, and NF-κB-dependent signaling (26) . In addition, ERK1/2, but not that of p38, pathway is required for the secretion of CCL2 from human monocytes infected with Mtb H37Rv (38). The present study shows that the 30-kDa-or TSPmediated CCL5 mRNA expression is dependent on ERK1/ 2, but not p38, signaling pathways. We also found that Collectively, results from our study suggest that altered CCL5 production is observed in PBMCs from active pulmonary TB patients, which might play an important role in immunopathogenesis during TB. There was no direct link between IFN-γ and CCL5 or CXCL8 levels. In addition, MEK1/2 and JAK2, but not p38, pathways are crucially involved in the CCL5 mRNA expression.
